Advanced renal cell carcinoma. Curr Treat Options Oncol. 2000; 1 :417–422.Bruce G., RedmanAlfred E., Chang. (2000) Advanced renal cell carcinoma. Current Treatment Options in Oncology 1 , 417-422 /Bruce G.Redman, Alfred E.Chang. (2000) Advanced renal cell carcinoma. Current Treatment ...
Experimental therapy for advanced renal cell carcinoma. Expert Opin Investig Drugs 2008;17: 1693-702. Stephen H. Culp Christopher G. Wood* University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA * Corresponding author. University of Texas M.D. Anderson Cancer Center, Urology, ...
1) advanced renal cell carcinoma 晚期肾癌例句>> 2) Mid and late stage renal carcinoma 中晚期肾癌 例句>> 3) Advanced gastric cancer 晚期胃癌 1. Preliminary clinical observation of paclitaxel based chemotherapy in the treatment of advanced gastric cancer; 紫杉醇联合化疗方案治疗晚期胃癌的临床疗效...
The management pathways of advanced renal cell carcinoma (RCC) have considerably evolved in the past 5 years, presenting a particular challenge during the coronavirus disease 2019 (COVID-19) pandemic. In this Comment, we propose a management algorithm on the basis of the current evidence to ...
Brian Rini, MD, and Hans Hammers, MD, PhD, discuss the evolution of management for advanced renal cell carcinoma (RCC), noting the role of biomarkers and its use in practice. This is a modal window. This video is either unavailable or not supported in this browser Error Code: MEDIA_ERR...
The panel discusses the lenvatinib plus everolimus regimen for patients with advanced renal cell carcinoma, highlighting clinical trial data on its efficacy and safety profile. EP: 1.Renal Cell Carcinoma: Risk Stratification and Evolving Treatment Landscape EP: 2.Case 1: Therapeutic Sequenci...
Objectives: The primary aim was to assess the efficacy oflocal advanced renal cell carcinomawith or without postoperative interferon-alpha adjuvant therapy, including the incidence of overall survival rate, Recurrence free rate. 目的:通过Meta—分析的方法比较局部进展性肾细胞癌根治性肾切除术+IFN-α辅助...
The availability of agents directly targeting tumorigenic and angiogenic pathways has significantly improved the outcomes of patients with advanced renal cell carcinoma (RCC) in recent years. However, all patients eventually become resistant and a substantial percentage experience immediate disease progression...
Molecular biomarkers for advanced renal cell carcinoma: Implications for prognosis and therapy The aim of this study was to determine reliable predictive biomarkers for patients with metastatic renal cell carcinomas (RCCs) who had received cytokine t... HS Kim,WS Kim,SH Park,... - 《Urologic ...
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation Cancer (0008543X)Jacopo PeccatoriLisbeth BarkholtTanner DemirerMaria Pia SormaniPaolo BruzziFabio CiceriAlberto ZambelliGian Antonio Da PradaPaolo PedrazzoliSalvatore Siena...